Visalytics
Visalytics
approved EB-2 (NIW)

Staff Scientist

Chemical Biology · China · 2025-03-03

Processing Time
115 days
Decision Date
2025-03-03
Location
Florida
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue developing novel anticancer therapeutics derived from microorganisms using integrated applications of genome mining, biosynthetic engineering, and synthetic biology to identify novel pathways and enzymes that improve drug efficacy, scalability, and safety.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses significant challenges in the pharmaceutical industry and supports national innovation in drug discovery and public health.

2 Well-positioned to Advance the Endeavor Met

The petitioner's track record of 20 publications, high citation count, and papers ranked in the top 1-20% of their field demonstrates their leadership and influence.

3 On Balance, Beneficial to Waive Job Offer Met

The petitioner's unique expertise in microbial bioengineering and the potential for improved cancer treatments provide a benefit to the U.S. that outweighs the need for labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's significant contributions to natural product discovery, including 20 peer-reviewed publications in high-impact journals like Nature Chemical Biology, over 410 citations, and 14 confirmed peer reviews. The work aligns with U.S. critical and emerging technologies in drug discovery.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Peer Review Service
Reference Letters
Original Contributions

Similar Cases

Physician

Biotechnology · China

WeGreened EB-2 (NIW) approved
27 days 2025-03-13
The petitioner proposes to focus on repurposing existing drugs for cancer treatment by leveraging advanced computational methods and bioinformatics tools. This work aims to enhance therapeutic options, improve patient outcomes, and significantly reduce the time and cost associated with traditional drug development.
View Case

Scientist

Pharmaceuticals · New Zealand

WeGreened EB-2 (NIW) approved
California 467 days 2025-03-05
The petitioner proposes to design and optimize novel small-molecule therapeutics to improve cancer patient outcomes, specifically targeting difficult-to-treat cancers. Their work involves leveraging synthetic organic chemistry and catalysis to develop innovative approaches for constructing biologically active lead compounds with enhanced pharmacological profiles.
View Case

Postdoctoral Researcher

Pharmaceuticals · Bangladesh

WeGreened EB-2 (NIW) approved
Illinois 535 days 2026-01-16
The petitioner proposes to continue research in clinical pharmaceutical sciences, specifically focusing on understanding cancer development at the molecular level. The work involves investigating mechanisms such as genome instability and replication stress to identify actionable molecular targets for cost-conscious therapeutic strategies.
View Case

Research Scientist

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
Maryland 470 days 2025-02-28
The petitioner proposes to continue research in molecular biology focusing on the roles of specific proteins and signaling pathways in cancer development. The work involves studying compounds that disrupt survival signals in cancer cells to design highly effective, targeted therapies. The goal is to improve patient survival rates and enhance the precision of cancer treatments globally.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-03-03.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 115 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist